prednisolone has been researched along with Lymphoma, B-Cell in 187 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We have previously described the effectiveness of the R-THP-COP regimen comprising rituximab, cyclophosphamide, pirarubicin, vincristine and prednisolone in patients with diffuse large B-cell lymphoma." | 9.16 | A phase II study of rituximab combined with pirarubicin-cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma. ( Fukuno, K; Goto, H; Goto, N; Hara, T; Kanemura, N; Kasahara, S; Kitagawa, J; Moriwaki, H; Sawada, M; Shimizu, M; Takahashi, T; Takami, T; Tsurumi, H; Yamada, T; Yoshikawa, T, 2012) |
| "To evaluate the efficacy of a combined modality treatment (MACOP-B plus mediastinal radiotherapy) and the advantages of Gallium-67-citrate single-photon emission ((67)GaSPECT) over computed tomography (CT) for restaging in patients with primary mediastinal large B-cell lymphoma (PMLBCL) with sclerosis." | 9.09 | Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients. ( Ascani, S; Bendandi, M; Magagnoli, M; Mandelli, F; Martelli, M; Martelli, MP; Orcioni, GF; Palombi, F; Pescarmona, E; Pileri, SA; Scaramucci, L; Tura, S; Zinzani, PL, 1999) |
| "Here we report three cases of hepatitis B virus (HBV) reactivation after cessation of preemptive lamivudine therapy in B-cell lymphoma patients treated with rituximab plus CHOP (R-CHOP)." | 7.75 | [Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy]. ( Fukai, K; Ise, M; Kojima, H; Kumagai, K; Mimura, N; Sakai, C; Takagi, T; Tsujimura, H; Yokosuka, O, 2009) |
| "We report a patient with rheumatoid arthritis (RA) who developed malignant lymphoma of the diffuse large B-cell type in the right submandibular region shortly after initiation of oral methotrexate (MTX)." | 7.72 | Malignant lymphoma associated with rheumatoid arthritis, developing shortly after initiation of oral methotrexate. ( Gono, T; Hoshi, K; Ikeda, S; Matsuda, M; Shikama, N; Shimojima, Y; Tokuda, T; Yamamoto, K, 2004) |
| "In this open-label, randomised, phase 3 trial done across 61 centres in Germany, patients aged 18-60 years with newly diagnosed, high-risk (age-adjusted International Prognostic Index [IPI] 2 or 3) aggressive B-cell lymphoma were randomly assigned (1:1, using Pocock minimisation) to eight cycles of conventional chemotherapy (cyclosphosphamide, doxorubicin, vincristine, etoposide, and prednisolone) plus rituximab (R-CHOEP-14) or four cycles of high-dose chemotherapy plus rituximab followed by autologous HSCT (R-MegaCHOEP)." | 5.41 | Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial. ( Altmann, B; Bentz, M; Borchmann, P; Dreyling, M; Frontzek, F; Glass, B; Haenel, M; Held, G; Horn, H; Kroschinsky, FP; Lenz, G; Loeffler, M; Metzner, B; Nickelsen, M; Ott, G; Rosenwald, A; Schmitz, N; Staiger, AM; Truemper, L; Viardot, A; Ziepert, M, 2021) |
| "Patients with histologically verified MALT lymphoma undergoing chemotherapy with MCP were evaluated retrospectively." | 5.32 | Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). ( Chott, A; Dirisamer, A; Drach, J; Hejna, M; Püspök, A; Raderer, M; Scheithauer, W; Wöhrer, S, 2003) |
| " We have previously described the effectiveness of the R-THP-COP regimen comprising rituximab, cyclophosphamide, pirarubicin, vincristine and prednisolone in patients with diffuse large B-cell lymphoma." | 5.16 | A phase II study of rituximab combined with pirarubicin-cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma. ( Fukuno, K; Goto, H; Goto, N; Hara, T; Kanemura, N; Kasahara, S; Kitagawa, J; Moriwaki, H; Sawada, M; Shimizu, M; Takahashi, T; Takami, T; Tsurumi, H; Yamada, T; Yoshikawa, T, 2012) |
| "We did an open-label, randomised trial comparing conventional chemotherapy (cyclophosphamide, doxorubicin, vincristine, etoposide, prednisone) and rituximab (R-CHOEP-14) with dose-escalated sequential HDT and rituximab (R-MegaCHOEP) followed by repetitive ASCT in high-risk (age-adjusted International Prognostic Index [IPI] 2 or 3) patients aged 18-60 years with aggressive B-cell lymphoma." | 5.16 | Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1). ( Bentz, M; Borchmann, P; Doelken, G; Ehninger, G; Glass, B; Haenel, M; Loeffler, M; Nickelsen, M; Peter, N; Pfreundschuh, M; Rosenwald, A; Ruebe, C; Schmidt, C; Schmitz, N; Truemper, L; Viardot, A; Ziepert, M, 2012) |
| "To evaluate the efficacy of a combined modality treatment (MACOP-B plus mediastinal radiotherapy) and the advantages of Gallium-67-citrate single-photon emission ((67)GaSPECT) over computed tomography (CT) for restaging in patients with primary mediastinal large B-cell lymphoma (PMLBCL) with sclerosis." | 5.09 | Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients. ( Ascani, S; Bendandi, M; Magagnoli, M; Mandelli, F; Martelli, M; Martelli, MP; Orcioni, GF; Palombi, F; Pescarmona, E; Pileri, SA; Scaramucci, L; Tura, S; Zinzani, PL, 1999) |
| "A 55-year-old woman with concurrent active thyroid orbitopathy and B-cell lymphoma developed acute exacerbation of thyroid orbitopathy after receiving Rituximab, cyclophosphamide, hydroxydaunorubicin, Prednisone (R-CHOP) chemotherapy, presenting with subtotal loss of vision and severe eyelid edema." | 3.88 | Chemotherapy-induced exacerbations of thyroid orbitopathy in a patient with B-cell lymphoma. ( Croon-de Boer, F; Dalm, VASH; Liu, C; Paridaens, D; van Hagen, PM, 2018) |
| "Here we report three cases of hepatitis B virus (HBV) reactivation after cessation of preemptive lamivudine therapy in B-cell lymphoma patients treated with rituximab plus CHOP (R-CHOP)." | 3.75 | [Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy]. ( Fukai, K; Ise, M; Kojima, H; Kumagai, K; Mimura, N; Sakai, C; Takagi, T; Tsujimura, H; Yokosuka, O, 2009) |
| " She had a history of rheumatoid arthritis (RA) for 26 years, and had been taking methotrexate and prednisolone." | 3.74 | [Case of malignant lymphoma associated with rheumatoid arthritis]. ( Kono, T; Noguchi, T; Nohara, J; Sakaguchi, Y; Terada, Y, 2008) |
| "The patient received oral prednisolone 15 mg daily for polymyalgia rheumatica along with alendronate 70 mg weekly." | 3.73 | A case of polymyalgia rheumatica, microscopic polyangiitis, and B-cell lymphoma. ( Chakravarty, K; Hakim, A; Hughes, R; Keat, A; Kuttikat, A, 2006) |
| "We report a patient with rheumatoid arthritis (RA) who developed malignant lymphoma of the diffuse large B-cell type in the right submandibular region shortly after initiation of oral methotrexate (MTX)." | 3.72 | Malignant lymphoma associated with rheumatoid arthritis, developing shortly after initiation of oral methotrexate. ( Gono, T; Hoshi, K; Ikeda, S; Matsuda, M; Shikama, N; Shimojima, Y; Tokuda, T; Yamamoto, K, 2004) |
| "CHOP-14 with the addition of rhG-CSF is safe and practicable in a large multicentre setting in patients aged 18-75 years." | 2.71 | Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). ( Bittner, S; Kloess, M; Loeffler, M; Pfreundschuh, M; Reiser, M; Rudolph, C; Schmalenberg, H; Schmits, R; Truemper, L; Wunderlich, A, 2003) |
| "Isolated gastric varices (IGV) can occur in patients with left-sided portal hypertension resulting from splenic vein occlusion caused by thrombosis or stenosis." | 2.49 | Isolated gastric variceal bleeding caused by splenic lymphoma-associated splenic vein occlusion. ( Chang, WK; Chen, BC; Hsieh, TY; Lin, YC; Shih, YL; Wang, HH, 2013) |
| "However, Wernicke encephalopathy (cerebral Beriberi), a clinical manifestation of thiamine deficiency, has rarely been associated with cancer patients." | 2.44 | Wernicke encephalopathy complicating lymphoma therapy: case report and literature review. ( Boniol, S; Boyd, M; Burton, GV; Koreth, R, 2007) |
| "Acute perforated appendicitis is a very rare initial presentation of appendiceal lymphoma." | 2.42 | Primary appendiceal lymphoma presenting as perforated acute appendicitis. ( Fu, TY; Tseng, HH; Wang, JS, 2004) |
| "Erythema nodosum is the most frequent clinicopathological variant of the panniculitides." | 2.42 | [Erythema nodosum association with malignant lymphoma]. ( Griniūte, R; Pileckyte, M, 2003) |
| " This study aimed to assess the efficacy and toxicity of dose-adjusted CHOP alone or in combination with rituximab (R-CHOP) by examining the stem cell mobilization in NHL patients." | 1.42 | Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma. ( Gui, L; Han, X; He, X; Liu, P; Qin, Y; Shi, Y; Yang, J; Yang, S; Yao, J; Zhang, C; Zhang, S; Zhao, L; Zhou, P; Zhou, S, 2015) |
| "Thereafter, local recurrence of pyothorax-associated lymphoma (PAL) at the primary site was seen." | 1.33 | CD20-negative pyothorax-associated B cell lymphoma. ( Fukuno, K; Kanemura, N; Moriwaki, H; Nishio, M; Okamoto, K; Tanabashi, S; Tsurumi, H, 2005) |
| "We report a patient in whom sudden hearing loss heralded IVL and propose that the hearing loss may have been the consequence of labyrinthine infarction consequent to the aggregation of malignant cells in the internal auditory artery." | 1.33 | Intravascular lymphomatosis presenting with sudden hearing loss. ( Berger, JR; Jones, R; Wilson, D, 2005) |
| "We examined the efficacy and adverse effects of rituximab with CHOP (cyclophosphamide, doxorubicin, vincristin, prednisone) or THP-COP (pirarubicin, cyclophosphamide, vincristin, prednisone) in previously untreated old-old and extremely old patients with diffuse large B cell lymphoma (DLBCL)." | 1.33 | [The efficacy and adverse effects of rituximab with CHOP or THP-COP in old-old and extremely old patients with diffuse large B cell lymphoma]. ( Abe, S; Fujii, H; Iwamoto, T; Kanaya, K; Kikukawa, M; Kiuchi, A; Miyazaki, K; Shin, K, 2006) |
| "Grade 3 follicular lymphoma (FL3) is thought to have an aggressive clinical course." | 1.32 | A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. ( Aoun, P; Armitage, JO; Bierman, PJ; Bociek, RG; Chan, WC; Greiner, TC; Hans, CP; Hock, LM; Lynch, JC; Vose, JM; Weisenburger, DD, 2003) |
| "We report a case of tracheoesophageal fistula (TEF) secondary to chemotherapy for primary thyroid lymphoma." | 1.32 | Tracheoesophageal fistula secondary to chemotherapy for malignant B-cell lymphoma of the thyroid: successful surgical treatment with jejunal interposition and mesenteric patch. ( Arai, W; Hosoya, Y; Hyodo, M; Nagai, H; Nishino, H; Sugawara, Y; Yasuda, Y; Yokoyama, T, 2004) |
| "Diagnosed as having a testicular tumor by ultrasonography and MRI, he underwent orchiectomy." | 1.32 | [Testicular malignant lymphoma: a case report]. ( Iwasawa, T; Kuroda, K; Masuda, E; Matsushima, M; Satou, D; Sawada, Y; Tajima, M; Takeuchi, Y; Yabuki, D, 2003) |
| "Patients with histologically verified MALT lymphoma undergoing chemotherapy with MCP were evaluated retrospectively." | 1.32 | Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). ( Chott, A; Dirisamer, A; Drach, J; Hejna, M; Püspök, A; Raderer, M; Scheithauer, W; Wöhrer, S, 2003) |
| "The diagnosis of Wegener's Granulomatosis (WG) was formed on the base of clinical features and result of pathologic examination of surgical specimen from the paranasal sinuses." | 1.31 | [Diffuse large B-cell lymphoma mimicking Wegener's granulomatosis]. ( Dobkowski, P; Gawryluk, D; Słodkowska, J; Wiatr, E, 2002) |
| "In this case, congestive heart failure developed even though the total dose of pirarubicin was lower than in previous reports of this complication." | 1.31 | [CHF arising after low dose THP-COP chemotherapy in an elderly patient with malignant lymphoma]. ( Doi, N; Fujimoto, S; Hashimoto, T; Matoba-Ueno, K; Nakamura, S; Nishino, T; Shiiki, H; Yamano, S, 2001) |
| "Multiple brain tumors were found and diagnosed as having B-cell, diffuse large cell type malignant lymphoma." | 1.30 | [A case of malignant lymphoma after renal transplantation]. ( Ikeda, K; Inoue, S; Matsuura, O; Murakami, S; Oyama, H; Sugiyama, T; Yamao, K, 1997) |
| "Pneumonitis is a well recognized side effect of this drug, but occurs at low doses in the treatment of NHL." | 1.30 | Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma. ( Bloor, AJ; Marcus, RE; Seale, JR, 1998) |
| "Our case rapidly fell into oliguria and acute renal failure, hence needed hemodialysis." | 1.30 | [A case of non-Hodgkin's lymphoma presenting with acute renal failure diagnosed by renal biopsy]. ( Hayashi, H; Inaguma, D; Ishihara, S; Kanoh, T; Kumon, S; Kurata, K; Machida, H; Yaomura, T, 1999) |
| "A 12-year-old girl suffering from Bloom's syndrome developed B-cell-type lymphoma in the epipharynx." | 1.28 | Treatment for B-cell-type lymphoma in a girl associated with Bloom's syndrome. ( Horie, H; Kinugawa, N; Kudoh, F; Miyamoto, S; Okimoto, Y; Oto, S, 1992) |
| "The initial clinical diagnosis was left testicular tumor." | 1.28 | Malignant lymphoma of the testis presenting as primary testicular tumor. ( Kanetake, H; Minami, Y; Nomata, K; Saha, PK; Saito, Y; Sakai, H, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 45 (24.06) | 18.2507 |
| 2000's | 103 (55.08) | 29.6817 |
| 2010's | 34 (18.18) | 24.3611 |
| 2020's | 5 (2.67) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, N | 1 |
| Ngayama, D | 1 |
| Watanabe, Y | 2 |
| Yamaguchi, T | 2 |
| Nakamura, S | 5 |
| Ohira, M | 1 |
| Saiki, A | 1 |
| Onda, H | 1 |
| Yamaoka, S | 1 |
| Abe, K | 2 |
| Nakaseko, C | 1 |
| Tatsuno, I | 1 |
| Sawaki, A | 1 |
| Miyazaki, K | 2 |
| Yamaguchi, M | 1 |
| Takeuchi, T | 1 |
| Kobayashi, K | 1 |
| Imai, H | 2 |
| Tawara, I | 1 |
| Ono, R | 1 |
| Nosaka, T | 1 |
| Katayama, N | 1 |
| Fujita, N | 1 |
| Ando, M | 2 |
| Goto, A | 1 |
| Sakata, M | 1 |
| Ogata, M | 1 |
| Usagawa, Y | 1 |
| Yoshikawa, H | 2 |
| Yamasue, M | 1 |
| Komiya, K | 1 |
| Umeki, K | 1 |
| Nureki, SI | 1 |
| Kadota, JI | 1 |
| Sparks, A | 1 |
| Woods, JP | 1 |
| Bienzle, D | 1 |
| Wood, GA | 1 |
| Coomber, BL | 1 |
| Frontzek, F | 1 |
| Ziepert, M | 2 |
| Nickelsen, M | 2 |
| Altmann, B | 1 |
| Glass, B | 3 |
| Haenel, M | 3 |
| Truemper, L | 4 |
| Held, G | 1 |
| Bentz, M | 2 |
| Borchmann, P | 2 |
| Dreyling, M | 1 |
| Viardot, A | 2 |
| Kroschinsky, FP | 1 |
| Metzner, B | 1 |
| Staiger, AM | 1 |
| Horn, H | 1 |
| Ott, G | 2 |
| Rosenwald, A | 2 |
| Loeffler, M | 5 |
| Lenz, G | 1 |
| Schmitz, N | 3 |
| Davies, O | 1 |
| Szladovits, B | 1 |
| Polton, G | 1 |
| Garden, OA | 1 |
| Leo, C | 1 |
| Lara-Garcia, A | 1 |
| Liu, C | 1 |
| Dalm, VASH | 1 |
| van Hagen, PM | 1 |
| Croon-de Boer, F | 1 |
| Paridaens, D | 1 |
| Valejo Coelho, MM | 1 |
| Borges, AS | 1 |
| Fernandes, C | 1 |
| Ribeiro, P | 1 |
| João, A | 1 |
| Carvalho, R | 1 |
| Ben Ayed, C | 1 |
| Laabidi, S | 1 |
| Said, N | 1 |
| Afrit, M | 1 |
| Ben Ahmed, S | 1 |
| Boussen, H | 1 |
| Kobayashi, H | 2 |
| Matsunaga, Y | 1 |
| Uchiyama, Y | 1 |
| Nagura, K | 1 |
| Komatsu, Y | 1 |
| Chen, BC | 1 |
| Wang, HH | 1 |
| Lin, YC | 1 |
| Shih, YL | 1 |
| Chang, WK | 1 |
| Hsieh, TY | 1 |
| Kanazawa, Y | 1 |
| Hagiwara, N | 1 |
| Matsuo, R | 1 |
| Arakawa, S | 1 |
| Ago, T | 1 |
| Kitazono, T | 1 |
| Sekiguchi, Y | 1 |
| Shimada, A | 1 |
| Wakabayashi, M | 1 |
| Sugimoto, K | 1 |
| Nakamura, N | 1 |
| Sawada, T | 1 |
| Komatsu, N | 1 |
| Noguchi, M | 1 |
| Kim, MJ | 1 |
| Hong, ME | 1 |
| Maeng, CH | 1 |
| Jung, HA | 1 |
| Hong, JY | 1 |
| Choi, MK | 1 |
| Kim, SJ | 2 |
| Ko, YH | 2 |
| Kim, WS | 2 |
| Shi, Y | 1 |
| Zhou, P | 1 |
| Han, X | 1 |
| He, X | 1 |
| Zhou, S | 1 |
| Liu, P | 1 |
| Yang, J | 1 |
| Zhang, C | 1 |
| Gui, L | 1 |
| Qin, Y | 1 |
| Yang, S | 1 |
| Zhao, L | 1 |
| Yao, J | 1 |
| Zhang, S | 1 |
| Kryachok, IA | 1 |
| Aleksyk, OM | 1 |
| Cartron, G | 1 |
| Hourcade-Potelleret, F | 1 |
| Morschhauser, F | 1 |
| Salles, G | 1 |
| Wenger, M | 1 |
| Truppel-Hartmann, A | 1 |
| Carlile, DJ | 1 |
| Hishikari, K | 1 |
| Kuwahara, T | 1 |
| Kimura, S | 1 |
| Hikita, H | 1 |
| Takahashi, A | 1 |
| Isobe, M | 1 |
| Tsuji, H | 1 |
| Mochiduki, A | 1 |
| Hosaka, A | 1 |
| Yoshizawa, T | 1 |
| Tamaoka, A | 1 |
| Vural, F | 1 |
| Saydam, G | 1 |
| Cagirgan, S | 1 |
| Ertekin, B | 1 |
| Hekimgil, M | 1 |
| Unal, I | 1 |
| Soydan, S | 1 |
| Tombuloglu, M | 1 |
| Gotoh, M | 1 |
| Kitahara, T | 1 |
| Iguchi, T | 1 |
| Izumi, M | 1 |
| Mukai, K | 2 |
| Ohyashiki, K | 2 |
| Asagi, A | 1 |
| Miyake, Y | 1 |
| Yasuhara, H | 1 |
| Matsumoto, K | 2 |
| Takahara, M | 1 |
| Kawai, D | 1 |
| Kaji, E | 1 |
| Toyokawa, T | 1 |
| Onishi, T | 1 |
| Miyatani, K | 1 |
| Nakatsu, M | 1 |
| Visani, G | 2 |
| Isidori, A | 2 |
| Inoue, D | 1 |
| Hamamura, T | 1 |
| Uehara, T | 1 |
| Miyoshi, K | 1 |
| Katsuragi, T | 1 |
| Takeshita, I | 2 |
| Hamada, T | 1 |
| Kabiri, el H | 1 |
| Kabiri, M | 1 |
| Doghmi, K | 1 |
| Chaiwun, B | 1 |
| Sukhamwang, N | 1 |
| Ya-In, C | 1 |
| Shuangshoti, S | 1 |
| Myung, J | 1 |
| Kim, B | 1 |
| Yoon, BW | 1 |
| Lee, SK | 1 |
| Sung, JJ | 1 |
| Chung, CK | 1 |
| Chang, KH | 1 |
| Park, SH | 2 |
| De Zan, G | 1 |
| Zappulli, V | 1 |
| Cavicchioli, L | 1 |
| Di Martino, L | 1 |
| Ros, E | 1 |
| Conforto, G | 1 |
| Castagnaro, M | 1 |
| Elkadi, D | 1 |
| Wiernik, PH | 1 |
| Tong, TR | 1 |
| Mimura, N | 1 |
| Tsujimura, H | 2 |
| Ise, M | 1 |
| Sakai, C | 2 |
| Kojima, H | 1 |
| Fukai, K | 1 |
| Yokosuka, O | 1 |
| Takagi, T | 2 |
| Kumagai, K | 2 |
| Montineri, A | 1 |
| Nigro, L | 1 |
| Chiarenza, A | 1 |
| Larocca, L | 1 |
| La Rosa, R | 1 |
| Iacobello, C | 1 |
| Di Raimondo, F | 1 |
| Fatuzzo, F | 1 |
| Tauro, S | 1 |
| Cochrane, L | 1 |
| Lauritzsen, GF | 1 |
| Baker, L | 1 |
| Delabie, J | 1 |
| Roberts, C | 1 |
| Mahendra, P | 1 |
| Holte, H | 1 |
| Yamashita, T | 1 |
| Sakaura, H | 1 |
| Oshima, K | 1 |
| Iwasaki, M | 1 |
| Babu, K | 1 |
| Murthy, KR | 1 |
| Krishnakumar, S | 1 |
| Kim, BJ | 1 |
| Park, HR | 1 |
| Roh, HJ | 1 |
| Jeong, DS | 1 |
| Kim, BS | 1 |
| Park, KW | 1 |
| Cho, SC | 1 |
| So, YT | 1 |
| Oh, SY | 1 |
| Itoh, S | 1 |
| Okada, N | 1 |
| Wakasa, T | 1 |
| Tsudo, M | 1 |
| Shintaku, M | 1 |
| Kimura, T | 1 |
| Horiguchi, Y | 1 |
| Rieger, M | 1 |
| Österborg, A | 1 |
| Pettengell, R | 1 |
| White, D | 1 |
| Gill, D | 1 |
| Walewski, J | 1 |
| Kuhnt, E | 1 |
| Pfreundschuh, M | 4 |
| Ho, AD | 1 |
| Giard, C | 1 |
| Avenel-Audran, M | 1 |
| Croué, A | 1 |
| Verret, JL | 1 |
| Martin, L | 1 |
| Riihijärvi, S | 1 |
| Taskinen, M | 1 |
| Jerkeman, M | 1 |
| Leppä, S | 1 |
| Thomas, A | 1 |
| Kong, J | 1 |
| Eisenberg, R | 1 |
| Merli, F | 1 |
| Angrilli, F | 1 |
| Ferrara, F | 1 |
| Alesiani, F | 1 |
| Bamrolia, N | 1 |
| Yadava, U | 1 |
| Anand, A | 1 |
| Chaudhuri, Z | 1 |
| Tsurumi, H | 2 |
| Hara, T | 1 |
| Goto, N | 1 |
| Kitagawa, J | 1 |
| Kanemura, N | 2 |
| Yoshikawa, T | 1 |
| Kasahara, S | 1 |
| Goto, H | 1 |
| Fukuno, K | 2 |
| Yamada, T | 1 |
| Sawada, M | 1 |
| Shimizu, M | 1 |
| Takahashi, T | 1 |
| Takami, T | 1 |
| Moriwaki, H | 2 |
| Zeynalova, S | 1 |
| Kaiser, U | 1 |
| Cavallin-Stahl, E | 1 |
| Wolf, M | 1 |
| Ganzenmueller, T | 1 |
| Karaguelle, D | 1 |
| Schmitt, C | 1 |
| Puppe, W | 1 |
| Stachan-Kunstyr, R | 1 |
| Bronzlik, P | 1 |
| Sauerbrei, A | 1 |
| Wegner, F | 1 |
| Heim, A | 1 |
| Ahn, JY | 1 |
| Seo, YH | 1 |
| Park, PW | 1 |
| Kim, KH | 1 |
| Park, MJ | 1 |
| Jeong, JH | 1 |
| Song, YH | 1 |
| Hou, Y | 1 |
| Wang, HQ | 2 |
| Ba, Y | 1 |
| Jedliński, I | 1 |
| Jamrozek-Jedlińska, M | 1 |
| Bugajski, P | 1 |
| Pyda, M | 1 |
| Poprawski, K | 1 |
| Schmidt, C | 1 |
| Peter, N | 1 |
| Ehninger, G | 1 |
| Doelken, G | 1 |
| Ruebe, C | 1 |
| Pranesh, N | 1 |
| Gawryluk, D | 1 |
| Słodkowska, J | 1 |
| Dobkowski, P | 1 |
| Wiatr, E | 1 |
| Hans, CP | 1 |
| Weisenburger, DD | 1 |
| Vose, JM | 1 |
| Hock, LM | 1 |
| Lynch, JC | 1 |
| Aoun, P | 1 |
| Greiner, TC | 1 |
| Chan, WC | 1 |
| Bociek, RG | 1 |
| Bierman, PJ | 1 |
| Armitage, JO | 1 |
| Mottl, H | 1 |
| Bajciova, V | 1 |
| Nemec, J | 1 |
| Al Shemmari, S | 1 |
| Al Awadi, S | 1 |
| Mounier, N | 1 |
| Briere, J | 1 |
| Gisselbrecht, C | 2 |
| Emile, JF | 1 |
| Lederlin, P | 1 |
| Sebban, C | 1 |
| Berger, F | 2 |
| Bosly, A | 1 |
| Morel, P | 1 |
| Tilly, H | 1 |
| Bouabdallah, R | 1 |
| Reyes, F | 1 |
| Gaulard, P | 1 |
| Coiffier, B | 2 |
| Takauchi, K | 1 |
| Kono, H | 1 |
| Ito, T | 1 |
| Zaima, K | 1 |
| Okumoto, S | 1 |
| Au, WY | 1 |
| Ma, SK | 1 |
| Wan, TS | 1 |
| Wang, EP | 1 |
| Lau, TC | 1 |
| Kwong, YL | 1 |
| Kawakami, K | 1 |
| Kadowaki, S | 1 |
| Pileckyte, M | 1 |
| Griniūte, R | 1 |
| Wunderlich, A | 1 |
| Kloess, M | 1 |
| Reiser, M | 1 |
| Rudolph, C | 1 |
| Bittner, S | 1 |
| Schmalenberg, H | 1 |
| Schmits, R | 1 |
| Kang, SM | 1 |
| Rim, SJ | 1 |
| Chang, HJ | 1 |
| Choi, D | 1 |
| Cho, SY | 1 |
| Cho, SH | 1 |
| Chung, N | 1 |
| Daum, S | 1 |
| Ullrich, R | 1 |
| Heise, W | 1 |
| Dederke, B | 1 |
| Foss, HD | 1 |
| Stein, H | 1 |
| Thiel, E | 1 |
| Zeitz, M | 1 |
| Riecken, EO | 1 |
| Oshiro, A | 1 |
| Nagasaki, A | 1 |
| Nakachi, A | 1 |
| Uchima, N | 1 |
| Hasegawa, H | 1 |
| Nakazato, T | 1 |
| Nakamoto, M | 2 |
| Kinjo, N | 1 |
| Kinjo, F | 2 |
| Taira, N | 1 |
| Masuda, M | 1 |
| Takasu, N | 1 |
| Sathiapalan, RK | 1 |
| Hainau, B | 1 |
| Al-Mane, K | 1 |
| Belgaumi, AF | 1 |
| Motegi, S | 1 |
| Nishizaki, Y | 1 |
| Muramatsu, C | 1 |
| Nakamura, H | 2 |
| Kobayashi, F | 1 |
| Shiozawa, H | 1 |
| Kamochi, J | 1 |
| Itakura, M | 1 |
| Shibuya, M | 1 |
| Ogawa, T | 1 |
| Matsuzaki, S | 1 |
| Kojima, M | 1 |
| Tanaka, H | 3 |
| Yamane, Y | 1 |
| Sugihara, S | 1 |
| Masawa, N | 1 |
| Wöhrer, S | 1 |
| Drach, J | 1 |
| Hejna, M | 1 |
| Scheithauer, W | 1 |
| Dirisamer, A | 1 |
| Püspök, A | 1 |
| Chott, A | 1 |
| Raderer, M | 1 |
| Nuss, D | 1 |
| Addicks, K | 1 |
| Lackner, K | 1 |
| Nakane, T | 1 |
| Yamane, T | 1 |
| Shibata, H | 1 |
| Aoyama, Y | 1 |
| Hasegawa, T | 1 |
| Sakamoto, C | 1 |
| Nakamae, H | 1 |
| Terada, Y | 3 |
| Ohta, K | 2 |
| Hino, M | 1 |
| Takeuchi, Y | 1 |
| Sawada, Y | 1 |
| Yabuki, D | 1 |
| Masuda, E | 1 |
| Satou, D | 1 |
| Iwasawa, T | 1 |
| Kuroda, K | 1 |
| Tajima, M | 1 |
| Matsushima, M | 1 |
| Uchino, K | 1 |
| Sameshima, H | 1 |
| Miyamoto, T | 1 |
| Iino, T | 1 |
| Kato, K | 2 |
| Henzan, H | 1 |
| Aoki, K | 1 |
| Nagafuji, K | 1 |
| Gondo, H | 1 |
| Harada, M | 1 |
| Gono, T | 1 |
| Shimojima, Y | 1 |
| Hoshi, K | 1 |
| Yamamoto, K | 2 |
| Tokuda, T | 1 |
| Shikama, N | 1 |
| Matsuda, M | 1 |
| Ikeda, S | 1 |
| Gergely, L | 1 |
| Aleksza, M | 1 |
| Váróczy, L | 1 |
| Ponyi, A | 1 |
| Sipka, S | 1 |
| Illés, A | 1 |
| Szegedi, G | 1 |
| Sekiguchi, N | 1 |
| Nishimoto, J | 1 |
| Tanimoto, K | 1 |
| Kusumoto, S | 1 |
| Onishi, Y | 1 |
| Watanabe, T | 3 |
| Kobayashi, Y | 2 |
| Asamura, H | 1 |
| Kagami, Y | 2 |
| Matsuno, Y | 1 |
| Tobinai, K | 2 |
| Hosoya, Y | 1 |
| Yokoyama, T | 1 |
| Arai, W | 1 |
| Hyodo, M | 1 |
| Nishino, H | 1 |
| Sugawara, Y | 1 |
| Yasuda, Y | 1 |
| Nagai, H | 1 |
| Nagashima, O | 1 |
| Takahashi, K | 1 |
| Sato, K | 1 |
| Suzuki, T | 2 |
| Fukuchi, Y | 1 |
| Isobe, Y | 1 |
| Oshimi, K | 1 |
| Masada, T | 1 |
| Matsumoto, Y | 1 |
| Kawai, N | 1 |
| Tamiya, T | 1 |
| Nagao, S | 1 |
| Schneider, T | 1 |
| Tóth, E | 1 |
| Molnár, Z | 1 |
| Várady, E | 1 |
| Deák, B | 1 |
| Horváth, A | 1 |
| Horváth, GI | 1 |
| Eid, H | 1 |
| Schneider, K | 1 |
| Lovey, J | 1 |
| Keresztes, S | 1 |
| Esik, O | 1 |
| Lengyel, Z | 1 |
| Rosta, A | 1 |
| Ohta, M | 1 |
| Matsuoka, S | 1 |
| Ikeda, K | 2 |
| Fu, TY | 1 |
| Wang, JS | 1 |
| Tseng, HH | 1 |
| Nishio, M | 1 |
| Tanabashi, S | 1 |
| Okamoto, K | 1 |
| Berger, JR | 1 |
| Jones, R | 1 |
| Wilson, D | 2 |
| Ohkubo, H | 1 |
| Yoshida, T | 1 |
| Takaku, T | 1 |
| Katagiri, T | 1 |
| Paku, J | 1 |
| Kasuga, I | 1 |
| Minemura, K | 1 |
| Gotoh, A | 1 |
| Serizawa, H | 1 |
| Burton, C | 1 |
| Djakovic, A | 1 |
| Zollner, U | 1 |
| Vordermark, D | 1 |
| Dietl, J | 1 |
| Bogle, MA | 1 |
| Riddle, CC | 1 |
| Triana, EM | 1 |
| Jones, D | 1 |
| Duvic, M | 1 |
| Le, K | 1 |
| Lim, A | 1 |
| Bullpitt, P | 1 |
| Wood, G | 1 |
| Miyahara, T | 1 |
| Oyabul, Y | 1 |
| Hayashi, T | 2 |
| Shimizu, S | 1 |
| Matsuoka, K | 1 |
| Avilés, A | 1 |
| Neri, N | 1 |
| Delgado, S | 1 |
| Pérez, F | 1 |
| Nambo, MJ | 1 |
| Cleto, S | 1 |
| Talavera, A | 1 |
| Huerta-Guzmán, J | 1 |
| Takenaka, S | 1 |
| Mitsudo, K | 1 |
| Inoue, K | 1 |
| Goto, T | 1 |
| Kadota, K | 1 |
| Fujii, S | 1 |
| Yamamoto, H | 1 |
| Fuku, Y | 1 |
| Hirono, A | 1 |
| Taba, M | 1 |
| Ikeda, A | 1 |
| Kojima, Y | 1 |
| Maekawa, J | 1 |
| Maekawa, S | 1 |
| Takahashi, N | 2 |
| Saeki, H | 1 |
| Nakamura, Y | 2 |
| Oonishi, T | 1 |
| Ueda, N | 1 |
| Lin, TY | 1 |
| Zhang, HY | 1 |
| Huang, Y | 1 |
| Guan, ZZ | 1 |
| Shen, T | 1 |
| Shi, YK | 1 |
| Zhu, J | 1 |
| Ke, XY | 1 |
| Shen, ZX | 1 |
| Yu, SY | 1 |
| Liu, T | 1 |
| Shi, XL | 1 |
| Kambayashi, T | 1 |
| Ono, N | 1 |
| Otrock, ZK | 1 |
| Shamseddine, AI | 1 |
| Taher, AT | 1 |
| Sakai, R | 1 |
| Kanamori, H | 1 |
| Ishigatsubo, Y | 1 |
| Yoshino, S | 1 |
| Matsumoto, T | 1 |
| Konomi, H | 1 |
| Hirahashi, M | 1 |
| Yao, T | 1 |
| Iida, M | 1 |
| Shirao, S | 1 |
| Kuroda, H | 1 |
| Kida, M | 1 |
| Watanabe, H | 1 |
| Matsunaga, T | 1 |
| Niitsu, Y | 1 |
| Konuma, Y | 1 |
| Hirayama, Y | 1 |
| Kohda, K | 1 |
| Ogura, M | 1 |
| Morishima, Y | 1 |
| Itoh, K | 1 |
| Igarashi, T | 1 |
| Hotta, T | 1 |
| Kinoshita, T | 1 |
| Ohashi, Y | 1 |
| Mori, S | 2 |
| Terauchi, T | 1 |
| Avanzi, GC | 1 |
| Castello, L | 1 |
| Sainaghi, PP | 1 |
| Bergamasco, L | 1 |
| Boldorini, R | 1 |
| Bartoli, E | 1 |
| Kikukawa, M | 1 |
| Kiuchi, A | 1 |
| Abe, S | 1 |
| Fujii, H | 1 |
| Kanaya, K | 1 |
| Shin, K | 1 |
| Iwamoto, T | 3 |
| Adde, M | 1 |
| Enblad, G | 1 |
| Hagberg, H | 1 |
| Sundström, C | 1 |
| Laurell, A | 1 |
| Kubota, Y | 2 |
| Hokama, A | 1 |
| Fujita, J | 1 |
| Laack, NN | 1 |
| Ballman, KV | 1 |
| Brown, PB | 1 |
| O'Neill, BP | 1 |
| Aydin, E | 1 |
| Akdoğan, MV | 1 |
| Yerli, H | 1 |
| Ozdemir, BH | 1 |
| Demirhan, B | 1 |
| Kundranda, MN | 1 |
| Daw, HA | 1 |
| Lee, J | 1 |
| Kim, K | 1 |
| Ahn, JS | 1 |
| Jung, CW | 1 |
| Lim, HY | 1 |
| Kang, WK | 1 |
| Park, K | 1 |
| Kim, YH | 1 |
| Park, C | 1 |
| Yoon, SH | 1 |
| Lee, WY | 1 |
| Chun, HK | 1 |
| Bouzani, M | 1 |
| Karmiris, T | 1 |
| Rontogianni, D | 2 |
| Delimpassi, S | 1 |
| Apostolidis, J | 1 |
| Mpakiri, M | 1 |
| Nikiforakis, E | 1 |
| Bernatsky, S | 1 |
| Ramsey-Goldman, R | 1 |
| Lachance, S | 1 |
| Pineau, CA | 1 |
| Clarke, AE | 1 |
| Odawara, J | 1 |
| Asada, N | 1 |
| Aoki, T | 1 |
| Yamakura, M | 1 |
| Takeuchi, M | 1 |
| Ohuchi, T | 1 |
| Matsue, K | 1 |
| Kuttikat, A | 1 |
| Keat, A | 1 |
| Hughes, R | 1 |
| Hakim, A | 1 |
| Chakravarty, K | 1 |
| Sugimoto, T | 1 |
| Matano, S | 1 |
| Nishijima, H | 1 |
| Kakuta, K | 1 |
| Inamura, K | 1 |
| Okamura, T | 1 |
| Munemoto, S | 1 |
| Satoh, S | 1 |
| Ishii, A | 1 |
| Rimsza, LM | 1 |
| Farinha, P | 1 |
| Fuchs, DA | 1 |
| Masoudi, H | 1 |
| Connors, JM | 1 |
| Gascoyne, RD | 1 |
| Takahashi, H | 1 |
| Kagawa, R | 1 |
| Takeda, R | 1 |
| Sakata, S | 1 |
| Yamamoto, M | 1 |
| Nishizaki, D | 1 |
| Takamatsu, T | 1 |
| Iwasa, Y | 1 |
| Kim, DH | 1 |
| Baek, JH | 1 |
| Chae, YS | 1 |
| Kim, YK | 1 |
| Kim, HJ | 1 |
| Park, YH | 1 |
| Song, HS | 1 |
| Chung, JS | 1 |
| Hyun, MS | 1 |
| Sohn, SK | 1 |
| Boniol, S | 1 |
| Boyd, M | 1 |
| Koreth, R | 1 |
| Burton, GV | 1 |
| Ekmekci, TR | 1 |
| Koslu, A | 1 |
| Sakiz, D | 1 |
| Barutcuoglu, B | 1 |
| Sumi, M | 1 |
| Ichikawa, N | 1 |
| Shimizu, I | 1 |
| Yotsumoto, M | 1 |
| Ueno, M | 1 |
| Akinyemi, E | 1 |
| Mai, L | 1 |
| Matin, A | 1 |
| Maini, A | 1 |
| Fujiwara, T | 1 |
| Ishizawa, K | 1 |
| Kohata, K | 1 |
| Yamamoto, J | 1 |
| Yamada, MF | 1 |
| Kameoka, J | 1 |
| Ichinohasama, R | 1 |
| Harigae, H | 1 |
| Sahni, C | 1 |
| Desai, S | 1 |
| Ohye, H | 1 |
| Fukata, S | 1 |
| Hirokawa, M | 2 |
| Noguchi, T | 1 |
| Nohara, J | 1 |
| Sakaguchi, Y | 1 |
| Kono, T | 1 |
| Falini, B | 1 |
| Venturi, S | 1 |
| Martélli, M | 2 |
| Santucci, A | 1 |
| Pileri, S | 1 |
| Pescarmona, E | 2 |
| Giovannini, M | 1 |
| Mazza, P | 1 |
| Martelli, MF | 1 |
| Pasqualucci, L | 1 |
| Saito, S | 1 |
| Hayashi, K | 1 |
| Ohnoshi, T | 1 |
| Kawashima, K | 1 |
| Matsutomo, S | 1 |
| Tagawa, S | 1 |
| Mizuta, J | 1 |
| Tada, A | 1 |
| Ueno, K | 1 |
| Kimura, I | 1 |
| Nagatani, T | 1 |
| Baba, N | 1 |
| Nakajima, H | 1 |
| Graziano, F | 1 |
| Cellerino, R | 1 |
| Menestrina, F | 1 |
| Nicoli, N | 1 |
| Gramazio, A | 1 |
| Latini, L | 1 |
| Piga, A | 1 |
| Kalra, PA | 1 |
| Wood, GN | 1 |
| O'Donoghue, DJ | 1 |
| Mamtora, H | 1 |
| Routledge, R | 1 |
| Armstrong, G | 1 |
| Sinnott, PJ | 1 |
| Jos, V | 1 |
| Johnson, RW | 1 |
| Waldek, S | 1 |
| Zanker, B | 1 |
| Schirmacher, P | 1 |
| Köhler, H | 1 |
| Miyake, O | 1 |
| Tsujihata, M | 1 |
| Itoh, H | 2 |
| Wakatsuki, A | 1 |
| Itatani, H | 2 |
| Morozumi, M | 1 |
| Takasu, H | 1 |
| Okada, M | 1 |
| Onizuka, T | 1 |
| Satou, S | 1 |
| Koike, M | 1 |
| Ishiyama, T | 1 |
| Tomoyasu, S | 1 |
| Tsuruoka, N | 1 |
| Ohta, H | 1 |
| Fujisawa, R | 1 |
| Yamaguchi, A | 1 |
| Tashiro, T | 1 |
| Garrett, TJ | 1 |
| Chadburn, A | 1 |
| Barr, ML | 1 |
| Drusin, RE | 1 |
| Chen, JM | 1 |
| Schulman, LL | 1 |
| Smith, CR | 1 |
| Reison, DS | 1 |
| Rose, EA | 1 |
| Michler, RE | 1 |
| Hattenhauer, MG | 1 |
| Pach, JM | 1 |
| Sasai, K | 1 |
| Yamabe, H | 1 |
| Haga, H | 1 |
| Tsutsui, K | 1 |
| Dodo, Y | 1 |
| Ishigaki, T | 1 |
| Shibamoto, Y | 1 |
| Abe, M | 1 |
| Fujikawa, I | 1 |
| Tei, T | 1 |
| Yagasaki, F | 1 |
| Nagata, K | 1 |
| Hamaguchi, H | 1 |
| Miyake, S | 1 |
| Goldwasser, F | 1 |
| Pico, JL | 1 |
| Cerrina, J | 1 |
| Fernandez, H | 1 |
| Pons, JC | 1 |
| Cosset, JM | 1 |
| Hayat, M | 1 |
| Tanaka, S | 1 |
| Sawada, N | 1 |
| Kamio, M | 1 |
| Mochizuki, T | 1 |
| Jacobs, U | 1 |
| Niese, D | 1 |
| Brensing, KA | 1 |
| Eis-Hübinger, A | 1 |
| Buszello, H | 1 |
| Klehr, HU | 1 |
| Kubo, M | 1 |
| Koga, M | 1 |
| Fujii, T | 1 |
| Kaneko, T | 1 |
| Yamashita, K | 1 |
| Kokubu, T | 1 |
| Gianni, AM | 1 |
| Bregni, M | 1 |
| Siena, S | 1 |
| Brambilla, C | 1 |
| Di Nicola, M | 1 |
| Lombardi, F | 1 |
| Gandola, L | 1 |
| Tarella, C | 1 |
| Pileri, A | 1 |
| Ravagnani, F | 1 |
| Valagussa, P | 1 |
| Bonadonna, G | 1 |
| Satoh, T | 1 |
| Tsushima, K | 1 |
| Hizawa, Y | 1 |
| Nakui, Y | 1 |
| Itoh, J | 1 |
| Tamura, Y | 1 |
| Saitoh, S | 1 |
| Taka-mi, H | 1 |
| Munakata, A | 1 |
| Kawamura, S | 1 |
| Kuwahara, Y | 1 |
| Hibi, H | 1 |
| Yanaoka, Y | 1 |
| Okishio, N | 1 |
| Hoshinaga, K | 1 |
| Naide, Y | 1 |
| Kasahara, M | 1 |
| Oyama, H | 1 |
| Yamao, K | 1 |
| Sugiyama, T | 1 |
| Matsuura, O | 1 |
| Murakami, S | 1 |
| Inoue, S | 2 |
| Ono, H | 1 |
| Yokozeki, H | 1 |
| Katayama, I | 1 |
| Nishioka, K | 1 |
| Kawabata, Y | 1 |
| Horiuchi, T | 1 |
| Hatakeyama, T | 1 |
| Saito, K | 1 |
| Kume, M | 2 |
| Nimura, T | 1 |
| Nishinari, T | 1 |
| Miura, AB | 1 |
| Creatsas, GK | 1 |
| Hassan, EA | 1 |
| Deligeoroglou, EK | 1 |
| Markaki, SG | 1 |
| Michalas, SP | 1 |
| Nonaka, Y | 1 |
| Nomura, T | 1 |
| Ogawa, M | 1 |
| Bloor, AJ | 1 |
| Seale, JR | 1 |
| Marcus, RE | 1 |
| Nishida, S | 1 |
| Kuroko, K | 1 |
| Hoshino, T | 1 |
| Shirai, C | 1 |
| Yamanouchi, J | 1 |
| Okada, T | 1 |
| Hasegawa, A | 1 |
| Iwasaki, H | 1 |
| Hirota, Y | 1 |
| Yokota, E | 1 |
| Matsumoto, I | 1 |
| Fierro, MT | 1 |
| Quaglino, P | 1 |
| Savoia, P | 1 |
| Verrone, A | 1 |
| Bernengo, MG | 1 |
| Yaomura, T | 1 |
| Hayashi, H | 1 |
| Kanoh, T | 1 |
| Kurata, K | 1 |
| Ishihara, S | 1 |
| Machida, H | 1 |
| Inaguma, D | 1 |
| Kumon, S | 1 |
| Nagatsuma, K | 1 |
| Tanomogi, H | 1 |
| Hasegawa, S | 1 |
| Shimizu, K | 1 |
| Zinzani, PL | 1 |
| Magagnoli, M | 1 |
| Scaramucci, L | 1 |
| Palombi, F | 1 |
| Bendandi, M | 1 |
| Martelli, MP | 1 |
| Ascani, S | 1 |
| Orcioni, GF | 1 |
| Pileri, SA | 1 |
| Mandelli, F | 1 |
| Tura, S | 1 |
| Shinbo, H | 1 |
| Nakanishi, T | 1 |
| Suzuki, K | 2 |
| Fujita, K | 1 |
| Hertzberg, MS | 1 |
| Schifter, M | 1 |
| Sullivan, J | 1 |
| Stapleton, K | 1 |
| Taura, Y | 1 |
| Yamazaki, H | 1 |
| Katou, T | 1 |
| Gabryś, K | 1 |
| Kacprzak, G | 1 |
| Wakamoto, H | 1 |
| Miyazaki, H | 1 |
| Tomita, H | 1 |
| Ishiyama, N | 1 |
| Várkonyi, J | 1 |
| Zalatnai, A | 1 |
| Timár, J | 1 |
| Matolcsi, A | 1 |
| Falus, A | 1 |
| Bencsáth, M | 1 |
| László, V | 1 |
| Pócsik, E | 1 |
| Kotlán, B | 1 |
| Császár, A | 1 |
| Sai, S | 1 |
| Murase, T | 1 |
| Vlasveld, LT | 1 |
| Ermens, AA | 1 |
| Sonnenberg, AA | 1 |
| Pauwels, P | 1 |
| Iwahashi, M | 1 |
| Iida, S | 1 |
| Sako, S | 1 |
| Kikuchi, H | 1 |
| Otsuka, E | 1 |
| Nasu, M | 1 |
| Lebel, E | 1 |
| Itzchaki, M | 1 |
| Munakata, S | 1 |
| Hirano, S | 1 |
| Yoshiyama, Y | 1 |
| Koizumi, M | 1 |
| Kobayasi, T | 1 |
| Hattori, T | 1 |
| McLaughlin, P | 1 |
| Matsuda, T | 1 |
| Okihama, Y | 1 |
| Egami, K | 1 |
| Wada, M | 1 |
| Yoshioka, M | 1 |
| Maeda, S | 1 |
| Onda, M | 1 |
| Cavalot, AL | 1 |
| Preti, G | 1 |
| Vione, N | 1 |
| Nazionale, G | 1 |
| Palonta, F | 1 |
| Fadda, GL | 1 |
| Matoba-Ueno, K | 1 |
| Fujimoto, S | 1 |
| Doi, N | 1 |
| Nishino, T | 1 |
| Yamano, S | 1 |
| Shiiki, H | 1 |
| Hashimoto, T | 1 |
| Baba, K | 1 |
| Yajima, M | 1 |
| Minagawa, N | 1 |
| Kazama, A | 1 |
| Hirayama, K | 1 |
| Nakamura, T | 1 |
| Fukazawa, A | 1 |
| Ohata, K | 1 |
| Sunayama, K | 1 |
| Kashiwabara, H | 1 |
| Maruyama, K | 1 |
| Konno, H | 1 |
| Miura, K | 1 |
| Tsirigotis, P | 1 |
| Economopoulos, T | 1 |
| Dervenoulas, J | 1 |
| Papageorgiou, E | 1 |
| Bollas, G | 1 |
| Mantzios, G | 1 |
| Kalantzis, D | 1 |
| Koumarianou, A | 1 |
| Raptis, S | 1 |
| Siemens, HJ | 1 |
| Gerke, P | 1 |
| Steinhoff, J | 1 |
| Roth-Isigkeit, A | 1 |
| Wagner, K | 1 |
| Brückner, S | 1 |
| Yanagiya, N | 1 |
| Nakae, H | 1 |
| Chubachi, A | 1 |
| Miura, I | 1 |
| Kollmar, O | 1 |
| Becker, S | 1 |
| Schilling, MK | 1 |
| Maurer, CA | 1 |
| McCluggage, WG | 1 |
| Wright, GD | 1 |
| Okumoto, T | 1 |
| Tomiyama, K | 1 |
| Ino, H | 1 |
| Kanaya, Y | 1 |
| Maruyama, S | 1 |
| Otani, J | 1 |
| Yokoyama, N | 1 |
| Soda, M | 1 |
| Wada, S | 1 |
| Kitamura, H | 1 |
| Matsuura, Y | 1 |
| Katayama, Y | 1 |
| Ohkawa, H | 1 |
| Kugai, N | 1 |
| Motoyoshi, K | 1 |
| Fuse, Y | 1 |
| Nagata, N | 1 |
| Kumagai, T | 1 |
| Enomoto, K | 1 |
| Maebou, A | 1 |
| Hara, H | 1 |
| Yoshimoto, T | 1 |
| Hirao, F | 1 |
| Utsunomiya, M | 1 |
| Takatera, H | 1 |
| Tsujimura, T | 1 |
| Wong, RC | 1 |
| Harrison, P | 1 |
| Oto, S | 1 |
| Miyamoto, S | 1 |
| Kudoh, F | 1 |
| Horie, H | 1 |
| Kinugawa, N | 1 |
| Okimoto, Y | 1 |
| Brousse, N | 1 |
| Peuchmaur, M | 1 |
| Bryon, PA | 1 |
| Diebold, J | 1 |
| Kwak, LW | 1 |
| Wilson, M | 1 |
| Weiss, LM | 1 |
| Doggett, R | 1 |
| Dorfman, RF | 1 |
| Warnke, RA | 1 |
| Horning, SJ | 1 |
| Saha, PK | 1 |
| Sakai, H | 1 |
| Nomata, K | 1 |
| Minami, Y | 1 |
| Kanetake, H | 1 |
| Saito, Y | 1 |
| Shimada, K | 1 |
| Sato, M | 1 |
| Haruyama, S | 1 |
| Ichikawa, T | 1 |
| Aono, G | 1 |
| Ohara, T | 1 |
| Ando, Y | 1 |
| Abe, R | 1 |
| Nozawa, Y | 1 |
| Wakasa, H | 1 |
| Williams, RE | 1 |
| Seywright, MM | 1 |
| Lever, R | 1 |
| Lucie, NP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Phase III Study to Compare Conventional Chemotherapy (CHOEP-14) + Rituximab vs High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation (Mega-CHOEP-21) + Rituximab in Younger Patients With Aggressive NHL[NCT00129090] | Phase 3 | 450 participants (Actual) | Interventional | 2003-03-31 | Completed | ||
| An Open-Label, Multi-Centre, Randomised, Phase Ib Study to Investigate the Safety and Efficacy of RO5072759 Given in Combination With CHOP, FC or Bendamustine Chemotherapy in Patients With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma[NCT00825149] | Phase 1 | 137 participants (Actual) | Interventional | 2009-02-28 | Completed | ||
| An Open-label, Multicentre, Nonrandomized, Dose-escalating Phase I/II Study, With a Randomized Phase II Part, to Investigate the Safety and Tolerability of RO5072759 Given as Monotherapy in Patients With CD20+ Malignant Disease.[NCT00517530] | Phase 1/Phase 2 | 134 participants (Actual) | Interventional | 2007-09-30 | Completed | ||
| Burkimab:Study Multicenter of Optimization of the Treatment of LLA-B and the Burkitt's Lymphoma in Adult Patients (From 15 Years Old)[NCT00388193] | Phase 2 | 20 participants (Anticipated) | Interventional | 2006-08-31 | Completed | ||
| A Phase II Trial of Irinotecan in Recurrent Glioma[NCT00003134] | Phase 2 | 64 participants (Actual) | Interventional | 1998-01-31 | Completed | ||
| Primary Central Nervous System Non-Hodgkins's Lymphoma (PCNSL): A Phase II Clinical Trial of Radiation Therapy and High Dose Corticosteroids for Elderly Patients (70 Years of Age and Older)[NCT00003278] | Phase 2 | 28 participants (Actual) | Interventional | 1998-03-31 | Completed | ||
| Retrospective Multicenter International Study on Prognostic Factors, Management And Outcome Of Primary Mediastinal Large B-Cell Lymphoma (PMLBCL) Patients With Central Nervous System (CNS) Involvement[NCT06024694] | 45 participants (Anticipated) | Observational | 2022-06-10 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Blood samples were taken on Day 1 (pre-infusion, end of infusion, 3-6 hours post-infusion) of Cycle 1. Nonlinear mixed-effects modeling (with NONMEM software) was used to analyze the pooled samples for dose-concentration-time data of obinutuzumab. (NCT00517530)
Timeframe: Day 1 of Cycle 1
| Intervention | µm/ml*day (Geometric Mean) |
|---|---|
| 400 mg - Phase I, NHL | 459 |
| 800 mg - Phase I, NHL | 993 |
| 1200 mg - Phase I, NHL | 1057 |
| 2000 mg - Phase I, NHL | 146 |
Duration of complete response was defined as the time from the first complete or partial response until disease progression (PD) or death, whichever occurred first. For non-Hodgkin's lymphoma participants, PD was defined as >= 50% increase from nadir in the sum of the products of the greatest diameters (SPD) of any previously identified abnormal node for participants with a partial response or non-responders or the appearance of any new lesion during or at the end of therapy. For chronic lymphocytic leukemia participants, PD was defined as: (1) A >= 50% increase from nadir in the SPD of any previously involved nodes, or in a single involved node, or the size of other lesions (eg, splenic or hepatic nodules); a lymph node with a short axis of < 1.0 cm must increase by >= 50% and to a size of 1.5×1.5 cm or > 1.5 cm in the longest axis. (2) Appearance of any new lesion > 1 cm in the short axis. (4) A new site that is PET-positive with histological confirmation. (NCT00517530)
Timeframe: by the end of the follow-up period in Phase II of the study (within 3 years, 4 months)
| Intervention | days (Median) |
|---|---|
| Phase II, iNHL | 523 |
| Phase II, aNHL | 298 |
| Phase II, CLL | 272.5 |
EFS is defined as the time from start of treatment to disease progression/relapse, death or, in case of early withdrawal from the treatment period, the (end) date of last dose, whatever comes first. (NCT00517530)
Timeframe: by the end of the follow-up period in Phase II of the study (within 3 years, 4 months)
| Intervention | participants (Number) |
|---|---|
| 400/400 mg - Phase II, iNHL | 5 |
| 1600/800 mg - Phase II, iNHL | 6 |
| 400/400 mg - Phase II, aNHL | 2 |
| 1600/800 mg - Phase II, aNHL | 3 |
| 1000/1000 mg - Phase II, CLL | 4 |
Dose-limiting toxicities were defined as obinutuzumab-related adverse events occurring within the first 28 days of each administration of obinutuzumab, with the exception of B-cell depletion and lymphopenia which are expected outcomes of treatment with obinutuzumab. (NCT00517530)
Timeframe: Baseline to 28 days after the last infusion of obinutuzumab (up to 6 months)
| Intervention | percentage of participants (Number) |
|---|---|
| 50/100 mg - Phase I, NHL | 0 |
| 100/200 mg - Phase I, NHL | 0 |
| 200/400 mg - Phase I, NHL | 0 |
| 400/800 mg - Phase I, NHL | 0 |
| 800/1200 mg - Phase I, NHL | 0 |
| 1200/2000 mg - Phase I, NHL | 0 |
| 1600/800 mg - Phase I, NHL | 0 |
| 400/800 mg - Phase I, CLL | 0 |
| 800/1200 mg - Phase I, CLL | 0 |
| 1200/2000 mg - Phase I, CLL | 0 |
| 1000/1000 mg - Phase I, CLL | 0 |
Best overall response (BOR) was defined as the percentage of participants with a complete response (CR) or partial response (PR) (NCT00517530)
Timeframe: by Cutoff Date: 31 March 2012 (within 3 years, 4 months)
| Intervention | percentage of participants (Number) |
|---|---|
| 400/400 mg - Phase II, iNHL | 33.3 |
| 1600/800 mg - Phase II, iNHL | 63.6 |
| 400/400 mg - Phase II, aNHL | 23.8 |
| 1600/800 mg - Phase II, aNHL | 36.8 |
| 1000/1000 mg - Phase II, CLL | 30.0 |
A PR was defined as a >=50% decrease in SPD of the 6 largest nodes or nodal masses; no increase in size of other nodes, liver, or spleen; regression of splenic and hepatic nodules by >=50% in their SPD or, for single nodules, in the long axis (CLL only); and no new disease sites. (NCT00517530)
Timeframe: by Cutoff Date: 31 March 2012 (within 3 years, 4 months)
| Intervention | percentage of participants (Number) |
|---|---|
| 400/400 mg - Phase II, iNHL | 22.2 |
| 1600/800 mg - Phase II, iNHL | 40.9 |
| 400/400 mg - Phase II, aNHL | 9.5 |
| 1600/800 mg - Phase II, aNHL | 21.1 |
| 1000/1000 mg - Phase II, CLL | 25.0 |
PFS was defined as the time from start of treatment to disease progression (PD) or death due to any cause, whichever occurred first. For non-Hodgkin's lymphoma participants, PD was defined as >= 50% increase from nadir in the sum of the products of the greatest diameters (SPD) of any previously identified abnormal node for participants with a partial response or non-responders or the appearance of any new lesion during or at the end of therapy. For chronic lymphocytic leukemia participants, PD was defined as: (1) A >= 50% increase from nadir in the SPD of any previously involved nodes, or in a single involved node, or the size of other lesions (eg, splenic or hepatic nodules); a lymph node with a short axis of < 1.0 cm must increase by >= 50% and to a size of 1.5×1.5 cm or > 1.5 cm in the longest axis. (2) Appearance of any new lesion > 1 cm in the short axis. (4) A new site that is positron emission tomography (PET)-positive with histological confirmation. (NCT00517530)
Timeframe: by the end of the follow-up period in Phase II of the study (within 3 years, 4 months)
| Intervention | days (Median) |
|---|---|
| 400/400 mg - Phase II, iNHL | 182 |
| 1600/800 mg - Phase II, iNHL | 361 |
| 400/400 mg - Phase II, aNHL | 78 |
| 1600/800 mg - Phase II, aNHL | 83 |
| 1000/1000 mg - Phase II, CLL | 324 |
(NCT00517530)
Timeframe: at Cycle 1 Day 1, Cycle 1 Day 8 and Cycle 8 (over 168 days)
| Intervention | micrograms/mL (Geometric Mean) | ||
|---|---|---|---|
| Cycle 1 Day 1 (n=3,3,3,0) | Cycle 1 Day 8 (n=0,0,3,3) | Cycle 8 (n=3,3,3,4) | |
| 1200 mg - Phase I, CLL | 307 | 437 | 741 |
| 2000 mg - Phase I, CLL | NA | 735 | 1730 |
| 400 mg - Phase I, CLL | 216 | NA | 485 |
| 800 mg - Phase I, CLL | 210 | NA | 573 |
Obinutuzumab serum pharmacokinetic (PK) parameters in NHL participants following ascending doses. (NCT00517530)
Timeframe: at Cycle 1 Day 1, Cycle 1 Day 8 and Cycle 8 (over 168 days)
| Intervention | µm/ml*day (Geometric Mean) | ||
|---|---|---|---|
| Cycle 1 Day 1 (n=4,6,6,0) | Cycle 1 Day 8 (n=0,4,6,6) | Cycle 8 (n=0,5,5,5) | |
| 1200 mg - Phase I, NHL | 307 | 449 | 1070 |
| 2000 mg - Phase I, NHL | NA | 714 | 1380 |
| 400 mg - Phase I, NHL | 134 | NA | NA |
| 800 mg - Phase I, NHL | 234 | 367 | 698 |
A complete response was defined as the disappearance of all evidence of disease (NHL) and symptoms; normalization of biochemical abnormalities (NHL); regression of lymph nodes and nodal masses to normal size; decrease of nodes in the sum of the products of the greatest diameters (SPD); regression in size of the spleen and/or liver, should not be palpable, and disappearance of nodules related to lymphoma (CLL). Complete/unconfirmed (CRu) response includes NHL patients with one or more of the following: 1) a residual lymph node mass greater than 1.5 cm in greatest transverse diameter that has regressed by more than 75% in the SPD; 2) Indeterminate bone marrow (increased number or size of aggregates without cytologic or architectural atypia). Complete Response with Incomplete Bone Marrow Recovery (CRi) was measured only in patients with CLL. (NCT00517530)
Timeframe: by Cutoff Date: 31 March 2012 (within 3 years, 4 months)
| Intervention | percentage of participants (Number) | ||
|---|---|---|---|
| CR | CRu | CRi | |
| 1000/1000 mg - Phase II, CLL | 5.0 | NA | 0.0 |
| 1600/800 mg - Phase II, aNHL | 15.8 | 0.0 | NA |
| 1600/800 mg - Phase II, iNHL | 13.6 | 9.1 | NA |
| 400/400 mg - Phase II, aNHL | 9.5 | 4.8 | NA |
| 400/400 mg - Phase II, iNHL | 5.6 | 5.6 | NA |
Patients who might benefit from retreatment were allowed to be treated again at the request of the investigator. (NCT00517530)
Timeframe: by Cutoff Date: 25 November 2013 (within 4 years, 2 months)
| Intervention | percentage of participants (Number) | ||
|---|---|---|---|
| Best overall response | Complete response | Partial response | |
| Retreated Participants | 62 | 23 | 38 |
B-cell depletion was defined in two ways: definition 1 - decrease below 5% baseline level and definition 2 - decrease below 0.04 x 109/L. B-cell recovery was defined in two ways: definition 1 - return to at least 50% of baseline level and definition 2 - return to at least 0.08 x 109/L. (NCT00517530)
Timeframe: by the end of Phase II (within 3 years, 4 months)
| Intervention | participants (Number) | |||||
|---|---|---|---|---|---|---|
| within 6 months (n=11,19,11,12,13) | within 9 months (n=8,17,6,5,10) | within 12 months (n=5,16,4,5,9) | within 18 months (n=4,13,3,3,8) | within 24 months (n=3,10,2,3,5) | after 24 months (n=3,4,1,2,0) | |
| 1000/1000 mg - Phase II, CLL | 3 | 0 | 3 | 2 | 2 | 0 |
| 1600/800 mg - Phase II, aNHL | 0 | 1 | 0 | 1 | 0 | 1 |
| 1600/800 mg - Phase II, iNHL | 0 | 0 | 2 | 1 | 2 | 0 |
| 400/400 mg - Phase II, aNHL | 0 | 0 | 1 | 0 | 1 | 0 |
| 400/400 mg - Phase II, iNHL | 0 | 0 | 0 | 0 | 2 | 1 |
18 reviews available for prednisolone and Lymphoma, B-Cell
| Article | Year |
|---|---|
Isolated gastric variceal bleeding caused by splenic lymphoma-associated splenic vein occlusion.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Constriction, Pathologic; Cycl | 2013 |
Intravascular large B-cell lymphoma with pontine involvement successfully treated with R-CHOP therapy and intrathecal administration: a case report and review of literature.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain Neopla | 2014 |
Primary cutaneous B-cell lymphoma: report of eight cases and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Comb | 2008 |
Nonpegylated liposomal doxorubicin in the treatment of B-cell non-Hodgkin's lymphoma: where we stand.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Do | 2009 |
[Erythema nodosum association with malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Dif | 2003 |
[Case of malignant lymphoma arising from the posterior mediastinum, with pleural effusion].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic | 2004 |
Primary appendiceal lymphoma presenting as perforated acute appendicitis.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Appendi | 2004 |
Wernicke encephalopathy complicating lymphoma therapy: case report and literature review.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2007 |
[Malignant lymphoma of the thyroid].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2007 |
[Primary malignant lymphoma of the urinary bladder].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Hu | 1994 |
[Primary non-Hodgkin lymphoma of the prostate: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Dau | 1993 |
[Malignant lymphoma of the penis: report of two cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 1997 |
[Diffuse B-cell lymphoma associated with hemophagocytic syndrome].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Epir | 1998 |
[A case of malignant lymphoma of the epididymis].
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality | 2000 |
Biotherapy for lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2000 |
Isolated primary non-Hodgkin's malignant lymphoma of the larynx.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Larynge | 2001 |
[Ileal perforation due to cytomegalovirus enteritis under chemotherapy for malignant lymphoma. Report of a case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytomegalovirus Infections; | 2001 |
[A primary malignant lymphoma of the appendix].
Topics: Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Combined Modality Therapy; Cy | 1990 |
17 trials available for prednisolone and Lymphoma, B-Cell
| Article | Year |
|---|---|
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Central | 2021 |
Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antigens, CD20; Antineoplastic Ag | 2016 |
Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antigens, CD20; Antineoplastic Ag | 2016 |
Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antigens, CD20; Antineoplastic Ag | 2016 |
Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antigens, CD20; Antineoplastic Ag | 2016 |
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cohort Studies; | 2010 |
Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Prot | 2011 |
A phase II study of rituximab combined with pirarubicin-cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2012 |
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Prot | 2012 |
Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2003 |
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2003 |
Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Co | 2003 |
Residual disease after chemotherapy in aggressive malignant lymphoma: the role of radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; | 2005 |
[Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, C | 2005 |
Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2006 |
Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2007 |
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cyta | 1995 |
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1997 |
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Citrates; Combined Modality Therap | 1999 |
Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Im | 1990 |
152 other studies available for prednisolone and Lymphoma, B-Cell
| Article | Year |
|---|---|
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) therapy increases carotid intima-media thickness and plaque score with von Willebrand factor activity elevation in patients with malignant lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Atherosclerosis; Carotid Intima-Media Thickness; Cyc | 2022 |
Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy.
Topics: Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytochrome P-45 | 2020 |
Diffuse Large B-Cell Lymphoma Arising from the Lesion of Chronic Lobar Atelectasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 2020 |
Whole genome sequencing analysis of high confidence variants of B-cell lymphoma in Canis familiaris.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Dog Di | 2020 |
Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B-cell multicentric lymphoma in the United Kingdom.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Anti | 2018 |
Chemotherapy-induced exacerbations of thyroid orbitopathy in a patient with B-cell lymphoma.
Topics: Administration, Oral; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy P | 2018 |
B-cell follicular lymphoma presenting as facial papules.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Facial Dermatos | 2018 |
Primary bone lymphoma: tunisian multicentric retrospective study about 32 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neo | 2018 |
Novel humanized anti-CD20 antibody BM-ca binds to a unique epitope and exerts stronger cellular activity than others.
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anti | 2013 |
[Case of intravascular large B-cell lymphoma (IVLBCL) with central nervous system symptoms diagnosed by renal biopsy].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; | 2014 |
Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2015 |
Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2015 |
[IMMUNOHISTOCHEMICAL FACTORS OF SMALL-CELL LYMPHOMAS AND CHOICE OF TREATMENT WTTH LEVEL INCLUSION].
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Trans | 2014 |
Reversible Atrial Fibrillation with Bradycardia Associated with Primary Cardiac B-Cell Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Atrioventricular Block; Bradyca | 2016 |
[Intravascular lymphomatosis manifesting clinically as subacute encephalopathy].
Topics: Acute Disease; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combin | 2008 |
[HIV-related multiple non-Hodgkin lymphomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophospham | 2008 |
[Case of primary malignant lymphoma of the liver treated by R-CHOP therapy].
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Co | 2009 |
[Intravascular lymphoma confirmed by brain biopsy, quickly treated by chemotherapy: a case report].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2009 |
[Primary non-Hodgkin lymphoma of the sternum].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Human | 2009 |
Bilateral low-grade B-cell lymphoma of the breast: a case report with cytological, histological and immunohistochemical studies.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Biopsy, Fine-Needle; Breast; C | 2009 |
B-cell dominant lymphocytic primary angiitis of the central nervous system: four biopsy-proven cases.
Topics: Adult; Antineoplastic Agents, Hormonal; B-Lymphocytes; Brain; Brain Neoplasms; Cyclophosphamide; Dia | 2010 |
Gastric B-cell lymphoma with Mott cell differentiation in a dog.
Topics: Animals; Anti-Ulcer Agents; Cell Differentiation; Cimetidine; Dog Diseases; Dogs; Euthanasia; Gastro | 2009 |
Resolution of massive pleural effusion due to lymphoma with intrapleural interleukin-2.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
[Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy].
Topics: Adult; Aged; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antine | 2009 |
Telbivudine use in a patient affected by occult hepatitis B virus and B-cell non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
Solitary intradural extramedullary lymphoma of the cervical spine.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Ant | 2010 |
Two successive ocular malignancies in the same eye of a HIV-positive patient: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blindness; Carcinoma, Squamous Cell; CD4 Lymp | 2010 |
Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2010 |
A case of cutaneous B-cell lymphoma showing multiple lipoatrophy-like skin depressions.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Co | 2010 |
Primary cutaneous Epstein-Barr virus-associated B-cell lymphoma arising at the site of subcutaneous injections of methotrexate.
Topics: Adrenal Cortex Hormones; Aged; Dermatologic Agents; Dermatomyositis; Epstein-Barr Virus Infections; | 2010 |
Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2011 |
Primary diffuse large B-cell lymphoma of the lacrimal sac.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Diagnos | 2010 |
The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia pro
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Muri | 2011 |
Bilateral retrobulbar neuritis in an adolescent boy with lymphoma.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; | 2011 |
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Age of Onset; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Che | 2012 |
Prolonged detection of herpes simplex virus type 2 (HSV-2) DNA in cerebrospinal fluid despite antiviral therapy in a patient with HSV-2-associated radiculitis.
Topics: Acyclovir; Aged; Antiviral Agents; DNA Copy Number Variations; DNA, Viral; Female; Herpes Simplex; H | 2012 |
A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child.
Topics: Antineoplastic Agents; Bone Marrow Cells; Child, Preschool; Chromosomes, Human, Pair 14; Chromosomes | 2012 |
Comparison on therapeutic effects of RFT and RCTVP regimen in the treatment of patients with indolent B-cell lymphoma in China.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2012 |
[Massive infiltration of the right vetricular wall caused by large B-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Echocardiography; Fat | 2012 |
Lymphoma in an ileostomy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colitis, Ulcerative; Combined Modal | 2002 |
[Diffuse large B-cell lymphoma mimicking Wegener's granulomatosis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Do | 2002 |
A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2003 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Presch | 2003 |
[A case of primary hepatic lymphoma successfully treated by THP-COP therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administra | 2003 |
Concurrent mediastinal B cell lymphoma and chronic myeloid leukemia with an unusually favorable response to chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Clone Cells; Combined Modal | 2003 |
[Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 11; | 2003 |
Primary cardiac lymphoma diagnosed by transvenous biopsy under transesophageal echocardiographic guidance and treated with systemic chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Echocardiogra | 2003 |
[A case of primary malignant lymphoma of the duodenum successfully treated with dose escalating chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Duodenal Neopla | 2003 |
Favorable response to treatment of a child with T-cell-rich large B-cell lymphoma presenting with liver failure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Humans; Liver; | 2003 |
Hemophagocytic syndrome in ileum-origin B-cell lymphoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 2003 |
Massive hyperplasia of marginal zone B-cells with clear cytoplasm in the lymph node: a case report.
Topics: Anti-Bacterial Agents; Antigens, CD; Axilla; B-Lymphocytes; Biomarkers; Biopsy; Cytoplasm; Diagnosis | 2003 |
Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP).
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Dis | 2003 |
[Focal concentrations in the hepatic CT in superior vena cava thrombosis].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antine | 2003 |
[Primary malignant lymphoma arising from the nipple and areolar area of the breast].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Fem | 2003 |
[Testicular malignant lymphoma: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 2003 |
Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2004 |
Malignant lymphoma associated with rheumatoid arthritis, developing shortly after initiation of oral methotrexate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Cycloph | 2004 |
Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-Posit | 2004 |
Primary mediastinal large B-cell lymphoma: a single-institution clinical study in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclopho | 2004 |
Tracheoesophageal fistula secondary to chemotherapy for malignant B-cell lymphoma of the thyroid: successful surgical treatment with jejunal interposition and mesenteric patch.
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxor | 2004 |
[Usefulness of FDG-PET in monitoring effects of the modality therapy for central nervous system malignant lymphoma: report of three cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cyclopho | 2004 |
[Treatment of primary mediastinal large B-cell lymphomas].
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleo | 2004 |
[Case of central nervous system lymphoma metastasized to breast after remission by methotrexate chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cytarabine; Fatal | 2005 |
CD20-negative pyothorax-associated B cell lymphoma.
Topics: Aged; Aged, 80 and over; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosph | 2005 |
Intravascular lymphomatosis presenting with sudden hearing loss.
Topics: Anti-Inflammatory Agents; Audiometry; Brain Neoplasms; Cerebellum; Corpus Callosum; Fatal Outcome; H | 2005 |
[A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2005 |
A 61-year-old man with dyspepsia and weight loss.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2005 |
[Mediastinal large B-cell lymphoma with symptomatic superior vena cava syndrome in a patient with bichorial twin pregnancy in the 26th week of gestation: peri-and postpartal management -- a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Cyclophosphamide; Doxorubic | 2005 |
Primary cutaneous B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Borrelia burgdorferi | 2005 |
Intravascular B-cell lymphoma diagnosed by skin biopsy.
Topics: Abdomen; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, D | 2005 |
[A case of malignant lymphoma of the prostate].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D | 2005 |
Successful treatment of primary cardiac lymphoma with atrioventricular nodal block.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administra | 2005 |
[Non-Hodgkin malignant lymphoma of rib origin: report of a case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyc | 2005 |
Non-Hodgkin disease in beta-thalassemia major.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; beta-Thalassemia; Child; Child, Preschool; Co | 2006 |
[Long-term remission after CHOP therapy in a case of multifocal extranodal diffuse large B-cell lymphoma with t(1 ; 14) (p22 ; q32) and rearrangement of bcl-10].
Topics: Adaptor Proteins, Signal Transducing; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Cell C | 2005 |
[A case of primary gastric malignant lymphoma perforated immediately after administration of chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphom | 2006 |
[Effective combined modality therapy for a patient with primary adrenal lymphoma].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Deriv | 2006 |
A malignant fibroleiomyoma of the testis.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Biopsy, Nee | 2006 |
[The efficacy and adverse effects of rituximab with CHOP or THP-COP in old-old and extremely old patients with diffuse large B cell lymphoma].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2006 |
Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14).
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antine | 2006 |
[A case of primary pulmonary malignant lymphoma associated with autoimmune hemolytic anemia].
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; | 2006 |
'The sandwich sign' of mesenteric lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 2006 |
Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neop | 2006 |
Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neop | 2006 |
Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neop | 2006 |
Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neop | 2006 |
[Non-Hodgkin's lymphoma of the parotid gland].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Dox | 2006 |
Stroke as a consequence of delayed treatment of a primary B-cell thyroid lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymph | 2006 |
Disseminated intravascular B-cell lymphoma: clinicopathological features and outcome of three cases treated with anthracycline-based immunochemotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2006 |
Lymphoma in a patient with systemic lupus erythematosus.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Doxor | 2006 |
18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorod | 2007 |
A case of polymyalgia rheumatica, microscopic polyangiitis, and B-cell lymphoma.
Topics: Aged; Alendronate; Antibodies, Antineutrophil Cytoplasmic; Antineoplastic Combined Chemotherapy Prot | 2006 |
[Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D | 2007 |
Fatal fulminant Clostridium difficile colitis during CHOP therapy for lymphoma: an autopsy case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Clostridioides difficile; Cyclophosph | 2007 |
HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 2007 |
Successfully-treated mesenteric non-Hodgkin's lymphoma involving hepatic mass--a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D | 2007 |
Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma.
Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Human | 2007 |
Primary cutaneous large B-cell lymphoma, leg type, presented with a migratory lesion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Humans; Leg; | 2007 |
[Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia].
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; | 2007 |
Diffuse large B-cell lymphoma mimicking advanced basal cell carcinoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2007 |
Aggressive B-cell lymphoma with dual surface immunoglobulin light-chain expression.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2007 |
Primary testicular precursor B-lymphoblastic lymphoma: a rare entity.
Topics: Adult; Age Factors; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide | 2007 |
[Case of malignant lymphoma associated with rheumatoid arthritis].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2008 |
[Non-Hodgkin's lymphoma of the bone, with reference to MRI findings following treatment].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Cycloph | 1993 |
[Lymphomas of the skin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Combined Modality | 1993 |
Synchronous primary hepatic lymphoma and epidermoid lung carcinoma treated with chemotherapy and surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; | 1995 |
Complete regression of recurrent diffuse malignant lymphoma after withdrawal of cyclosporin A in a renal transplant recipient.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Ki | 1994 |
[Bilateral kidney enlargement with kidney failure. Manifestation of primary extranodal B-cell lymphoma after long-term immunosuppression].
Topics: Azathioprine; Female; Humans; Hypertrophy; Kidney; Kidney Failure, Chronic; Kidney Neoplasms; Lupus | 1994 |
[Parapsoriasis en plaque suspected of progression to mycosis fungoides associated with extranodal malignant B cell lymphoma of the cheek].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cheek; Cyclophosphamide; Doxorubicin; Facial Neoplas | 1993 |
Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Immuno | 1993 |
Ocular lymphoma in a patient with chronic lymphocytic leukemia.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biopsy; Combined Modality Therapy; Eye Neo | 1996 |
Non-Hodgkin's lymphoma of the thyroid. A clinical study of twenty-two cases.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Anti | 1996 |
[Autopsy case of angiotropic lymphoma complicated with interstitial pneumonia during VEPA therapy and monocytosis in the early stage].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capillaries; Cyclophosphamide; Doxorubicin; He | 1996 |
Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Follow-Up Studies; Humans | 1995 |
[Long-term survivor (15 years) following central nervous system involvement in B-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; | 1996 |
Immunologic disorders in posttransplant lymphoma: therapeutic implications.
Topics: Adult; Antigens, CD; Azathioprine; B-Lymphocytes; Cyclosporine; Herpesviridae Infections; Herpesviru | 1996 |
Bilateral adrenal lymphoma with neoplastic angioendotheliosis.
Topics: Acute Kidney Injury; Addison Disease; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy | 1997 |
[Combination chemotherapy with BH-AC, mitoxantrone, etoposide, and prednisolone to refractory or relapsed malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedul | 1997 |
[A case of malignant lymphoma after renal transplantation].
Topics: Adult; Azathioprine; Brain Neoplasms; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immuno | 1997 |
Granuloma annulare in a patient with malignant lymphoma.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormona | 1997 |
[Autologous peripheral blood stem cell transplantation for CHOP-resistant mediastinal diffuse large B-cell lymphoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Dr | 1997 |
Non-Hodgkin's ovarian lymphoma during adolescence: report of two cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Combined Mo | 1997 |
Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etop | 1998 |
[A case of primary malignant lymphoma of the bladder].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administr | 1998 |
[Acute mitral regurgitation caused by malignant lymphoma of the posterior mediastinum].
Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 1998 |
Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOP.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marro | 1998 |
[A case of non-Hodgkin's lymphoma presenting with acute renal failure diagnosed by renal biopsy].
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxor | 1999 |
[A case of malignant lymphoma of the testis: characterization with ultrasonography and magnetic resonance imaging].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D | 1999 |
[A case of primary malignant lymphoma of the bladder].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration S | 1999 |
Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: significant responses to cyclophosphamide and prednisolone.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Fa | 2000 |
[Two cases of intravascular lymphomatosis diagnosed antemortem by transbronchial lung biopsy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Humans; | 2000 |
[A case of massive chylothorax during the course of malignant lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chylothorax; Cyclophosphamide; Doxorubicin; Dr | 1999 |
[Perineural spreading along the trigeminal nerve in a patient with primary intracranial malignant lymphoma: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cavernous Sinus; Cranial Nerve Neop | 2000 |
Secondary cutaneous infiltration in B cell chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Histidi | 2000 |
Elevated serum CA-125 concentrations due to expression by a diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-125 Antigen; Cyclophosphamide; | 2000 |
Primary effusion lymphoma with B-cell phenotype.
Topics: Aged; Antigens, CD; Antineoplastic Agents, Hormonal; Female; Gene Rearrangement; Genes, Immunoglobul | 2000 |
[Lymphoma of the knee joint simulating patellar fracture].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D | 1999 |
[Beneficial effects of CHOP therapy in a case of intravascular large B-cell lymphoma diagnosed by skin biopsy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Humans; Lymph | 2000 |
Complete cure of malignant lymphoma of the stomach with a huge adrenal lesion achieved by preoperative chemotherapy and surgery: report of a case.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2001 |
[CHF arising after low dose THP-COP chemotherapy in an elderly patient with malignant lymphoma].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; | 2001 |
[Testicular malignant lymphoma: report of two cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Doxo | 2001 |
T-cell-rich B-cell lymphoma. Analysis of clinical features, response to treatment, survival and comparison with diffuse large B-cell lymphoma.
Topics: Aged; Antigens, CD; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide | 2001 |
A prolonged APTT in a patient with a low grade malignant NHL - a case report.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Coagulation Factors; C | 2002 |
[Plasma exchange and continuous hemodiafiltration as an initial treatment for diffuse large B-cell lymphoma-associated hemophagocytic syndrome].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hemodiafiltrati | 2002 |
Intestinal lymphoma perforations as a consequence of highly effective anti-CD20 antibody therapy.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic | 2002 |
Urticarial vasculitis: a paraneoplastic presentation of B-cell non-Hodgkin's lymphoma.
Topics: Drug Therapy, Combination; Female; Humans; Lymphoma, B-Cell; Methotrexate; Middle Aged; Paraneoplast | 2002 |
[A case of malignant lymphoma of the stomach in which preoperative chemotherapy provided a complete response].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Gastrec | 2002 |
Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma.
Topics: Aclarubicin; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Calcitriol | 1992 |
[A case of mediastinal malignant lymphoma with cardiac tamponade treated effectively with chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cardiac Tamponade; Cyclophosphamide; Doxorubic | 1992 |
Bilateral primary non-Hodgkin's lymphoma of the adrenal glands with adrenal insufficiency: a case report.
Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Aged; Antineoplastic Combined Chemotherapy Protocols | 1992 |
NonEBV-related B-cell lymphoma in a renal transplant patient responding to acyclovir and reduction in immunosuppression.
Topics: Acyclovir; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunocompromised | 1992 |
Treatment for B-cell-type lymphoma in a girl associated with Bloom's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bloom Syndrome; Child; Chromosome Aberrations; Cyclo | 1992 |
Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclopho | 1991 |
Malignant lymphoma of the testis presenting as primary testicular tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 1991 |
Angiotropic B-cell lymphoma (malignant angioendotheliomatosis): failure of systemic chemotherapy.
Topics: Aged; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; F | 1990 |